Company Valuation: Aarti Drugs Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 64,755 39,725 31,280 39,886 31,240 32,565 - -
Change - -38.65% -21.26% 27.51% -21.68% 4.24% - -
Enterprise Value (EV) 64,755 39,725 31,280 39,886 31,240 32,565 32,565 32,565
Change - -38.65% -21.26% 27.51% -21.68% 4.24% 0% 0%
P/E ratio 23.1x 19.4x 18.8x 23.4x 18.5x 17.8x 14.4x 12.2x
PBR 7.09x 3.83x 2.62x 3.11x 2.27x 2.15x 1.93x 1.72x
PEG - -0.7x -1x 7.13x -16.35x 1.98x 0.6x 0.7x
Capitalization / Revenue 3.01x 1.6x 1.15x 1.58x 1.31x 1.25x 1.1x 0.98x
EV / Revenue 0x 0x 0x 0x 0x 1.25x 1.1x 0.98x
EV / EBITDA 0x 0x 0x 0x 0x 10.2x 8.13x 7.01x
EV / EBIT 0x 0x 0x 0x 0x 12.7x 9.97x 8.47x
EV / FCF 0x -0x -0x 0x 0x 35.7x 31.4x 27x
FCF Yield 1.03% -1.86% -0.97% 3.32% 2.16% 2.8% 3.19% 3.7%
Dividend per Share 2 2.5 1 - 1 - 4 5.4 7.3
Rate of return 0.36% 0.23% - 0.23% - 1.12% 1.51% 2.05%
EPS 2 30.09 22.12 17.97 18.56 18.35 20 24.7 29.2
Distribution rate 8.31% 4.52% - 5.39% - 20% 21.9% 25%
Net sales 1 21,548 24,886 27,160 25,286 23,870 26,066 29,472 33,182
EBITDA 1 4,371 3,294 3,056 3,165 2,871 3,206 4,008 4,645
EBIT 1 3,872 2,794 2,553 2,650 2,313 2,569 3,266 3,843
Net income 1 2,804 2,050 1,663 1,714 1,682 1,822 2,253 2,666
Net Debt - - - - - - - -
Reference price 2 694.80 429.00 337.80 433.85 339.80 356.80 356.80 356.80
Nbr of stocks (in thousands) 93,200 92,600 92,600 91,935 91,935 91,270 - -
Announcement Date 15/05/21 09/05/22 29/04/23 03/05/24 06/05/25 - - -
1INR in Million2INR
Estimates

P/E ratio, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
17.66x - - 1.13% 35Cr
29.39x11.07x22.23x0.66% 89TCr
25.78x6x16.34x2.18% 59TCr
24.73x6.77x13.58x3.04% 40TCr
17.77x4.33x10.71x3.05% 34TCr
24.42x5.09x14.09x1.71% 30TCr
21.17x5.7x14.1x2.84% 30TCr
27.16x4.76x14.89x2.9% 29TCr
25.41x6.42x11.43x2.66% 20TCr
20.24x6.16x11.14x2.23% 18TCr
Average 23.37x 6.25x 14.28x 2.24% 34.9TCr
Weighted average by Cap. 25.10x 7.05x 15.92x 2.08%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. AARTIDRUGS Stock
  4. Valuation Aarti Drugs Limited
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW